| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.07 |